Systemic lupus erythematosus

• A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus Not authorised
  2024-520385-57-00 3 "Systemic Lupus Erythematosus"
• Clinical trial comparing the efficacy and safety of certolizumab pegol and belimumab in patients with moderate or severe activity of systemi … Pending
  2024-517753-27-01 5 "moderate or severe activity of systemic lupus erythematosus "
• Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on … Pending
  2024-518191-31-00 6 "Inflammatory rheumatic disease"
• Clinical Study to Evaluate the Effects of Cevostamab in Patients with Lupus with or without Active Lupus Nephritis Pending
  2025-522904-26-00 3 "Systemic Lupus Erythematosus (SLE) With or Without Active Lu"
• A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythema … Pending
  2025-523670-17-00 5
• A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product Recruiting
  2024-520222-11-00 3 2026-03-03 "Hematological or solid tumor malignancies or autoimmune dise"
• A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of surovatamig in adult participants with rheumatoid art … Recruiting
  2025-522273-10-00 3 2026-02-24 "Systemic Lupus Erythematosus"
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Partic … Recruiting
  2024-519157-10-00 3 2025-11-24 "Systemic Lupus Erythematosus"
• Steroid withdrawal in SLE Recruiting
  2024-518580-35-00 6 2024-11-20 "Systemic Lupus Erythematosus"
• A randomized, two-period crossover study to demonstrate the comparability of pharmacokinetics of subcutaneous ianalumab between 2mL auto-inj … Recruiting
  2023-508996-35-00 4 2024-11-18 "Rheumatoid Arthritis"
• A study of anifrolumab in children and adolescents (5 to < 18 years old) with moderate to severe lupus to find the appropriate anifrolumab d … Recruiting
  2022-502289-25-00 5 2024-08-28 "Moderate to Severe Active Systemic Lupus Erythematosus"
• A Study to understand the Effectiveness, Safety, and what the body does to Mosunetuzumab in participants with Systemic Lupus Erythematosus w … Recruiting
  2024-519930-22-00 4 2026-05-18 "Systemic Lupus Erythematosus (SLE) With or Without Active Lu"
• A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults with Moderate to Severe Systemic Lupus E … Recruiting
  2025-523552-31-00 5 2026-05-07 "Systemic Lupus Erythematosus"
• Randomised, controlled phase II proof-of-concept trial to assess the efficacy of abaCavIr/lamivudine treatment on the interferon signature i … Recruiting
  2023-508611-22-00 4 2026-02-03 "systemic lupus"
• A phase I/II study of CAR-T cells in AutoiMmune disease resistant to B cell Abrogation - CARAMBA Recruiting
  2025-521530-28-00 9 2026-01-19 "Progressive systemic autoimmune disease resistant to B cell "
• A Phase 1b open label pilot study of CLN-978 for the treatment of moderate to severe systemic lupus erythematosus (SLE) Recruiting
  2024-518780-36-00 3 2025-12-10 "Systemic Lupus Erythematosus"
• A Phase 1 Study of the Safety and Preliminary Efficacy of CTX112 in Adult Subjects With Refractory Autoimmune Disease. Recruiting
  2024-518528-54-00 1 2025-12-02 "Active systemic lupus erythematosus (SLE), systemic sclerosi"
• A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus Recruiting
  2024-520385-57-01 3 2025-11-26 "Systemic Lupus Erythematosus"
• A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese and Japanese Participants, a … Recruiting
  2024-514186-18-00 1 2025-09-09 "Systemic Lupus Erythematosus"
• Long-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors. Recruiting
  2024-511684-28-00 4 2025-09-01 "Potential malignancy in patients who received treatment with"
• A Phase 1 Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases Recruiting
  2024-517681-41-00 1 2025-08-29 "Systemic Sclerosis"
• A phase I/II study of CAR-expressing Allogenic iPSC derived NK cells for treatment of autoiMmune disease by B cELl depletion - CARAMEL Recruiting
  2024-519532-16-00 9 2025-07-30 "Idiopathic inflammatory myositis"
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants with Systemic Lupus Ery … Recruiting
  2024-519015-34-00 1 2025-06-30 "Systemic Lupus Erythematosus"
• A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) i … Recruiting
  2023-507613-10-01 7 2025-03-31 "Active Systemic Lupus Erythematosus;Systemic lupus erythemat"

Showing 1–24 of 61 trials